Skip to main content
Clinical Trials/JPRN-C000000249
JPRN-C000000249
Unknown
Phase 2

A phase II study of percutaneous trans-esophageal gastric tubing for malignant gastrointestinal obstruction (JIVROSG-0205) - Percutaneous trans-esophageal gastric tubing (JIVROSG-0205)

Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 sites33 target enrollmentSeptember 1, 2006

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Malignant gastrointestinal obstruction
Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Enrollment
33
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 1, 2006
End Date
May 1, 2006
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Tracheostomy. 2\) Intestinal obstruction due to the lesions between transverse colon and rectum. 3\) Pregnancy. 4\) Local therapy for neck region

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Clinical study on the efficacy of trans-esophageal motor evoked potentialsaortic aneurysm, aortic dissection, traumatic aortic injury
JPRN-UMIN000022320Hamamatsu University School of Medicine100
Completed
Not Applicable
Diagnostic efficacy and safety of transesophageal endoscopic ultrasound with bronchoscope-guided fine needle aspiration (EUS-B-FNA) for the patients with lung cancer with respiratory failure
JPRN-UMIN000041235Third department of internal medicine, Universtiy of Fukui30
Recruiting
Not Applicable
Evaluation of endoscopic treatment of lower backache associated with lower limb pain.Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere
CTRI/2020/06/025594Maulana Azad Medical College
Not yet recruiting
Not Applicable
Evaluating the effect of ultrasound guided pacemaker or defibrillator lead implantation on tricuspid regurgitation.
ACTRN12620001070921Royal Prince Alfred Hospital125
Recruiting
Phase 4
The outcomes following Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion (PETLIF) and Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery (MIS-TLIF) for the treatment of lumbar disease: a randomized controlled trialPatients who diagnosed Degenerative Lumbar disease, causing Lumbar spondylolisthesis, lumbar discherniated, Lumbar spinal stenosis.Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion, PETLIF, Endo-TLIF, Minimally Invasive Transforaminal Lumbar Interbody Fusion surgery, MIS-TLIF, TLIF, Degenerative Lumbar disease
TCTR20240708003Faculty of Medicine Ramathibodi Hospital, Mahidol University44